If there was any doubt whether the entire active pharmaceutical ingredient (API) industry is a target for continued FDA scrutiny, it should be gone. Donald Ashley, director of FDA’s Office of Compliance, talked about major concerns the agency has with the API industry at the Association for Accessible Medicines’ conference. As reported in an
Continue ReadingPerhaps the most recognizable supply chain challenge linked to a product recall is the Takata airbag recall, which has so far impacted 19 automakers and 37 million vehicles over the course of several years. Because of the growing global length and complexity of supply chains, most product recalls today bring added layers of liability and reputational risk for several companies. We discussed
Continue Reading